Last edition
News about
Dr. Reddys Laboratories Unveils Broad-Spectrum Antibiotics in USA
Dr. Reddy’s Laboratories Ltd. has introduced Doxycycline Capsules, 40 mg in the US market.
ProPharma and PBL Develop Cell and Gene Therapy Manufacturing Device
ProPharma has announced its collaboration with PBL and have jointly developed an enclosed, fully automated cell factory device, the Cell Factory Box (CF Box).
MedRes Opens Medical Device Technology Center in Carlsbad, CA
The Carlsbad site is equipped to accelerate customer projects in the fields of cardiovascular intervention and minimally invasive surgery.
Anaut Announces Japanese Regulatory Approval of AI-Powered Surgical Visualization Tool, Eureka
Anaut Inc., a pioneering developer in surgical support software led by CEO Dr. Nao Kobayashi, announced regulatory approval of its groundbreaking medical device, 'Eureka α'.
Astellas Signs License Deal with Poseida to Develop Novel Allogeneic Cell Therapies
Astellas Pharma Inc. has announced that Xyphos Biosciences, Inc., a wholly owned subsidiary of Astellas and Poseida have signed a research collaboration and license agreement to develop novel convertibleCAR programs by combining the innovative cell therapy platforms from each of the companies.
Bayer Acquires Zydus Pharma with Full Ownership
Bayer Pharmaceuticals Private Ltd. and Zydus Lifesciences Ltd. have announced the successful conclusion of their joint venture (JV) - Bayer Zydus Pharma Private Ltd. (BZPPL).
Myonex Acquires Creapharm to Expand Global Services
Myonex has completed the acquisition of CREAPHARM’s pharmaceutical services business.
BrioHealth Solutions Receives FDA Approval to Begin Trial for Advanced Heart Failure Solution
The BrioVAD Left Ventricular Assist System offers both temporary and long-term support solutions for patients suffering from advanced heart failure.
MCRA Facilitates FDA Approval for Darmiyan's De Novo request for BrainSee
Darmiyan retained MCRA in 2021 for its broad and deep experience in Neurology, Digital Health, and Artificial Intelligence (AI).
Pepper Bio to Gain Exclusive Rights for Clinical Development of Lerociclib
G1 Therapeutics, Inc. has inked a global licensing agreement (excluding the Asia-Pacific region) with Pepper Bio for lerociclib for all indications except for certain radioprotectant uses.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy